SI-BONE, INC. Research and Development Expense
SI-BONE, INC. (SIBN) reported Research and Development Expense of $5.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- SI-BONE, INC. research and development expense for the quarter ending 2026-06-30 was $5.22M, a 21.17% increase year-over-year.
- SI-BONE, INC. research and development expense for the quarter ending 2026-03-31 was $4.19M, a 7.54% decline year-over-year.
- SI-BONE, INC. research and development expense for the quarter ending 2025-12-31 was $4.36M, a 12.74% increase year-over-year.
- SI-BONE, INC. research and development expense for the quarter ending 2025-09-30 was $4.24M, a 6.24% increase year-over-year.
- SI-BONE, INC. research and development expense for fiscal 2025 was $17.45M, a 5.36% increase from fiscal 2024.
- SI-BONE, INC. research and development expense for fiscal 2024 was $16.56M, a 10.19% increase from fiscal 2023.
- SI-BONE, INC. research and development expense for fiscal 2023 was $15.03M, a 10.28% increase from fiscal 2022.
- SI-BONE, INC. research and development expense for fiscal 2022 was $13.63M, a 9.53% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.22M 10-Q · filed 2026-08-04 | $9.41M 10-Q · filed 2026-08-04 | $13.78M derived: sum of 3 quarters · filed 2026-08-04 | $18.02M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $4.19M 10-Q · filed 2026-05-11 | $8.55M derived: sum of 2 quarters · filed 2026-05-11 | $12.80M derived: sum of 3 quarters · filed 2026-05-11 | $17.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.61M derived: sum of 2 quarters · filed 2026-02-24 | $12.91M derived: sum of 3 quarters · filed 2026-08-04 | $17.45M 10-K · filed 2026-02-24 |
| 2025-09-30 | $4.24M 10-Q · filed 2025-11-10 | $8.55M derived: sum of 2 quarters · filed 2026-08-04 | $13.09M 10-Q · filed 2025-11-10 | $16.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $4.31M 10-Q · filed 2026-08-04 | $8.84M 10-Q · filed 2026-08-04 | $12.71M derived: sum of 3 quarters · filed 2026-08-04 | $16.71M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.53M 10-Q · filed 2026-05-11 | $8.40M derived: sum of 2 quarters · filed 2026-05-11 | $12.40M derived: sum of 3 quarters · filed 2026-05-11 | $16.75M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.86M derived: sum of 2 quarters · filed 2026-02-24 | $12.21M derived: sum of 3 quarters · filed 2026-02-24 | $16.56M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.99M 10-Q · filed 2025-11-10 | $8.35M derived: sum of 2 quarters · filed 2025-11-10 | $12.69M 10-Q · filed 2025-11-10 | $16.85M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $4.35M 10-Q · filed 2025-08-05 | $8.70M 10-Q · filed 2025-08-05 | $12.86M derived: sum of 3 quarters · filed 2026-02-24 | $16.78M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $4.34M 10-Q · filed 2025-05-06 | $8.51M derived: sum of 2 quarters · filed 2026-02-24 | $12.43M derived: sum of 3 quarters · filed 2026-02-24 | $16.08M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.08M derived: sum of 2 quarters · filed 2026-02-24 | $11.74M derived: sum of 3 quarters · filed 2026-02-24 | $15.03M 10-K · filed 2026-02-24 |
| 2023-09-30 | $3.92M 10-Q · filed 2024-11-12 | $7.58M derived: sum of 2 quarters · filed 2024-11-12 | $10.87M 10-Q · filed 2024-11-12 | $14.35M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $3.66M 10-Q · filed 2024-08-06 | $6.95M 10-Q · filed 2024-08-06 | $10.43M derived: sum of 3 quarters · filed 2025-02-25 | $13.52M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $3.29M 10-Q · filed 2024-05-07 | $6.77M derived: sum of 2 quarters · filed 2025-02-25 | $9.86M derived: sum of 3 quarters · filed 2025-02-25 | $13.34M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $6.57M derived: sum of 2 quarters · filed 2025-02-25 | $10.05M derived: sum of 3 quarters · filed 2025-02-25 | $13.63M 10-K · filed 2025-02-25 |
| 2022-09-30 | $3.09M 10-Q · filed 2023-11-07 | $6.57M derived: sum of 2 quarters · filed 2023-11-07 | $10.15M 10-Q · filed 2023-11-07 | $13.20M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.48M 10-Q · filed 2023-08-08 | $7.06M 10-Q · filed 2023-08-08 | $10.11M derived: sum of 3 quarters · filed 2023-08-08 | $13.39M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $3.58M 10-Q · filed 2023-05-02 | $6.63M derived: sum of 2 quarters · filed 2023-05-02 | $9.92M derived: sum of 3 quarters · filed 2023-05-02 | $13.07M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $6.34M derived: sum of 2 quarters · filed 2023-03-02 | $9.49M derived: sum of 3 quarters · filed 2023-03-02 | $12.44M 10-K · filed 2023-03-02 |
| 2021-09-30 | $3.29M 10-Q · filed 2022-11-08 | $6.44M derived: sum of 2 quarters · filed 2022-11-08 | $9.39M 10-Q · filed 2022-11-08 | $11.82M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.15M 10-Q · filed 2022-08-09 | $6.10M 10-Q · filed 2022-08-09 | $8.53M derived: sum of 3 quarters · filed 2022-08-09 | $11.31M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $2.96M 10-Q · filed 2022-05-10 | $5.38M derived: sum of 2 quarters · filed 2022-05-10 | $8.16M derived: sum of 3 quarters · filed 2022-05-10 | $10.32M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.20M derived: sum of 2 quarters · filed 2022-03-01 | $7.37M derived: sum of 3 quarters · filed 2022-03-01 | $9.46M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.78M 10-Q · filed 2021-11-09 | $4.94M derived: sum of 2 quarters · filed 2021-11-09 | $7.03M 10-Q · filed 2021-11-09 | $8.81M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.17M 10-Q · filed 2021-08-04 | $4.25M 10-Q · filed 2021-08-04 | $6.03M derived: sum of 3 quarters · filed 2021-08-04 | $7.91M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.09M 10-Q · filed 2021-05-04 | $3.87M derived: sum of 2 quarters · filed 2021-05-04 | $5.74M derived: sum of 3 quarters · filed 2021-05-04 | $7.69M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $3.65M derived: sum of 2 quarters · filed 2021-03-10 | $5.60M derived: sum of 3 quarters · filed 2021-03-10 | $7.28M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.87M 10-Q · filed 2020-11-03 | $3.82M derived: sum of 2 quarters · filed 2020-11-03 | $5.50M 10-Q · filed 2020-11-03 | $7.00M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $1.95M 10-Q · filed 2020-08-04 | $3.63M 10-Q · filed 2020-08-04 | $5.13M derived: sum of 3 quarters · filed 2020-08-04 | $6.50M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $1.68M 10-Q · filed 2020-05-05 | $3.18M derived: sum of 2 quarters · filed 2020-05-05 | $4.56M derived: sum of 3 quarters · filed 2020-05-05 | $5.85M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $2.87M derived: sum of 2 quarters · filed 2020-03-11 | $4.17M derived: sum of 3 quarters · filed 2020-03-11 | $5.38M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.37M 10-Q · filed 2019-11-12 | $2.67M derived: sum of 2 quarters · filed 2019-11-12 | $3.88M 10-Q · filed 2019-11-12 | $5.15M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.30M 10-Q · filed 2019-08-07 | $2.50M 10-Q · filed 2019-08-07 | $3.78M derived: sum of 3 quarters · filed 2019-08-07 | $5.25M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $1.21M 10-Q · filed 2019-05-09 | $2.48M derived: sum of 2 quarters · filed 2019-05-09 | $3.95M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.75M derived: sum of 2 quarters · filed 2019-03-14 | $5.51M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.47M 10-Q · filed 2018-11-29 | $4.23M 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |